Cullinan Oncology Inc

NASDAQ:CGEM 3:59:41 PM EDT

31.23

-0.86 (-2.68%)

Market Cap (Intraday)	1.36B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$19 Million
Adjusted EPS	-$0.07

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Cullinan Oncology Inc Stock, NASDAQ:CGEM

One Main Street, Suite 520, Cambridge, Massachusetts 02142

United States of America

Phone: +1.617.410.4650

Number of Employees: 24

Description

Cullinan Oncology, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.